# Ophthalmic and Topical Dosage Form New Animal Drugs; Milbemycin Oxime Solution
> **Food and Drug Administration** · Final rule. · Published 2001-03-08 · Effective 2001-03-08 · 66 FR 13848
## Document
- **Document number:** 01-5684
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 66 FR 13848
- **CFR reference:** 21 CFR 524
- **Publication date:** 2001-03-08
- **Effective date:** 2001-03-08
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Novartis Animal Health US, Inc. The supplemental NADA provides for veterinary prescription use of milbemycin oxime solution to treat ear mite infestations in cats and kittens 4 weeks of age and older and for a repeat treatment, if necessary.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2001/03/08/01-5684/ophthalmic-and-topical-dosage-form-new-animal-drugs-milbemycin-oxime-solution)
---
*AI Analytics · CC0 1.0*